Tag Archives: license

Uppers and downers trading review (IDCC, DGX, WDC)

Posted on January 24, 2012 by Cameron White

In this report: InterDigital (NASDAQ:IDCC), Quest Diagnostics (NYSE:DGX) and Western Digital (NYSE:WDC).

InterDigital (NASDAQ:IDCC) is trading over 19 percent lower today after the company’s board announced that it had ended a strategic review in which it was looking at a …

Posted in Latest Headlines, Reports | Tagged analyst, board, Buy, company, DGX, earnings, expectations, IDCC, InterDigital, investors, license, NASDAQ:IDCC, Needham, net income, NYSE, NYSE:DGX, NYSE:WDC, quarter, Quest Diagnostics, rating, report, repurchase, revenue, sale, sell, selloff, speculation, stock, strategic, target price, trading, upgrade, Wall Street, WDC, Western Digital | Comments Off

Wednesday’s small cap movers (ALZM, CNOZ, GTGP)

Posted on December 21, 2011 by Josie Middleton

In this report: Allezoe Medical Holdings (ALZM:OB), Cono Italiano (CNOZ:OB) and Global Technologies (GTGP:OB).

Allezoe Medical Holdings (ALZM:OB) soared to 6 cents per share today before settling at its current price of 4 cents per share, a 5.94 percent gain …

Posted in Latest Headlines, Reports | Tagged 012, Aequorea, Allezoe Medical Holdings, ALZM, ALZM:OB, CNOZ, CNOZ:OB, company, Cono Italiano, deal, developer, dividends, facility, frozen food line, Global Technologies, GTGP, GTGP:OB, HPV diagnostic, issuance, license, licensing, share, share holders, technology | Comments Off

4 stocks to watch (PEIX, TSRA, LDK, GERN)

Posted on November 16, 2011 by Cameron White

In this report: Pacific Ethanol (NASDAQ:PEIX), Tessera Technologies (NASDAQ:TSRA), LDK Solar (NYSE:LDK) and Geron Corp. (NASDAQ:GERN).

Pacific Ethanol (NASDAQ:PEIX) is trading more than 24 percent higher today at $1.65 per share. The company announced that i had retired in full …

Posted in Latest Headlines, Reports | Tagged agreement, analyst, commercial, common stock, company, convertible notes, cut, downgraded, estimate, GERN, Geron Corp., gross margin, guidance, Hold, Kaufman Bros, LDK, LDK Solar, license, NASDAQ, NASDAQ:GERN, NASDAQ:PEIX, NASDAQ:TSRA, NYSE, NYSE:LDK, outlook, Pacific Ethanol, patents, patients, PEIX, rating, restructuring, revenue, Samsung Electronics, sell, Speculative Buy, stem cell, strong buy, technology, Tessera Technologies, therapy, trading, TSRA, WBB Securities | Comments Off

Immunomedics drops over 5 percent despite better than expected earnings

Posted on August 24, 2011 by pmarek

Immunomedics is down more than 5.9 percent today after the company reported fourth quarter earnings despite beating what analysts had expected.

The drug developer reported earnings of $2.3 million, or 3 cents a share for the three months which ended …

Posted in Healthcare, Latest Headlines | Tagged analyst, developer, drug, earnings, fees, fiscal, IMMU, Immunomedics, license, loss, NASDAQ, NASDAQ:IMMU, period, predictions, quarter, reported, revenue, trades | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

Tag Archives: license

Uppers and downers trading review (IDCC, DGX, WDC)

4 stocks to watch (PEIX, TSRA, LDK, GERN)

Immunomedics drops over 5 percent despite better than expected earnings

Follow us

Most Popular Posts

blogs